nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—CYP1B1—Dexamethasone—ankylosing spondylitis	0.128	0.155	CbGbCtD
Mitoxantrone—ABCG2—Sulfasalazine—ankylosing spondylitis	0.121	0.148	CbGbCtD
Mitoxantrone—ABCC1—Methotrexate—ankylosing spondylitis	0.0728	0.0887	CbGbCtD
Mitoxantrone—ABCG2—Dexamethasone—ankylosing spondylitis	0.0606	0.0738	CbGbCtD
Mitoxantrone—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0578	0.0704	CbGbCtD
Mitoxantrone—ABCG2—Methotrexate—ankylosing spondylitis	0.0487	0.0593	CbGbCtD
Mitoxantrone—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0432	0.0527	CbGbCtD
Mitoxantrone—ABCB1—Betamethasone—ankylosing spondylitis	0.0376	0.0458	CbGbCtD
Mitoxantrone—ABCB1—Prednisolone—ankylosing spondylitis	0.0371	0.0452	CbGbCtD
Mitoxantrone—ABCB1—Prednisone—ankylosing spondylitis	0.035	0.0427	CbGbCtD
Mitoxantrone—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0346	0.0422	CbGbCtD
Mitoxantrone—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0262	0.032	CbGbCtD
Mitoxantrone—CYP3A4—Betamethasone—ankylosing spondylitis	0.0225	0.0274	CbGbCtD
Mitoxantrone—CYP3A4—Prednisolone—ankylosing spondylitis	0.0222	0.0271	CbGbCtD
Mitoxantrone—ABCB1—Dexamethasone—ankylosing spondylitis	0.0219	0.0266	CbGbCtD
Mitoxantrone—CYP3A4—Prednisone—ankylosing spondylitis	0.021	0.0256	CbGbCtD
Mitoxantrone—ABCB1—Methotrexate—ankylosing spondylitis	0.0176	0.0214	CbGbCtD
Mitoxantrone—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0131	0.016	CbGbCtD
Mitoxantrone—TOP2A—Methyltestosterone—Prednisone—ankylosing spondylitis	0.000762	0.506	CbGdCrCtD
Mitoxantrone—TOP2A—Methyltestosterone—Prednisolone—ankylosing spondylitis	0.000743	0.494	CbGdCrCtD
Mitoxantrone—Bradycardia—Prednisone—ankylosing spondylitis	0.00035	0.00197	CcSEcCtD
Mitoxantrone—Alopecia—Betamethasone—ankylosing spondylitis	0.000349	0.00197	CcSEcCtD
Mitoxantrone—Alopecia—Dexamethasone—ankylosing spondylitis	0.000349	0.00197	CcSEcCtD
Mitoxantrone—Discomfort—Prednisolone—ankylosing spondylitis	0.000347	0.00195	CcSEcCtD
Mitoxantrone—Haemoglobin—Prednisone—ankylosing spondylitis	0.000346	0.00195	CcSEcCtD
Mitoxantrone—Haemorrhage—Prednisone—ankylosing spondylitis	0.000344	0.00194	CcSEcCtD
Mitoxantrone—Erythema—Dexamethasone—ankylosing spondylitis	0.000344	0.00194	CcSEcCtD
Mitoxantrone—Erythema—Betamethasone—ankylosing spondylitis	0.000344	0.00194	CcSEcCtD
Mitoxantrone—Malaise—Triamcinolone—ankylosing spondylitis	0.000342	0.00193	CcSEcCtD
Mitoxantrone—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000341	0.00192	CcSEcCtD
Mitoxantrone—Malaise—Methylprednisolone—ankylosing spondylitis	0.000341	0.00192	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000336	0.0019	CcSEcCtD
Mitoxantrone—Oedema—Prednisolone—ankylosing spondylitis	0.000336	0.0019	CcSEcCtD
Mitoxantrone—Neutropenia—Methotrexate—ankylosing spondylitis	0.000336	0.00189	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000334	0.00188	CcSEcCtD
Mitoxantrone—Shock—Prednisolone—ankylosing spondylitis	0.000331	0.00186	CcSEcCtD
Mitoxantrone—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000331	0.00186	CcSEcCtD
Mitoxantrone—Cough—Triamcinolone—ankylosing spondylitis	0.000331	0.00186	CcSEcCtD
Mitoxantrone—Convulsion—Triamcinolone—ankylosing spondylitis	0.000328	0.00185	CcSEcCtD
Mitoxantrone—Tachycardia—Prednisolone—ankylosing spondylitis	0.000328	0.00185	CcSEcCtD
Mitoxantrone—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000328	0.00185	CcSEcCtD
Mitoxantrone—Hypertension—Triamcinolone—ankylosing spondylitis	0.000327	0.00184	CcSEcCtD
Mitoxantrone—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000326	0.00184	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000325	0.00183	CcSEcCtD
Mitoxantrone—Myalgia—Triamcinolone—ankylosing spondylitis	0.000323	0.00182	CcSEcCtD
Mitoxantrone—Pneumonia—Methotrexate—ankylosing spondylitis	0.000322	0.00182	CcSEcCtD
Mitoxantrone—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000322	0.00181	CcSEcCtD
Mitoxantrone—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000322	0.00181	CcSEcCtD
Mitoxantrone—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000321	0.00181	CcSEcCtD
Mitoxantrone—Drowsiness—Methotrexate—ankylosing spondylitis	0.00032	0.0018	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000319	0.0018	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000319	0.0018	CcSEcCtD
Mitoxantrone—Discomfort—Triamcinolone—ankylosing spondylitis	0.000319	0.0018	CcSEcCtD
Mitoxantrone—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000318	0.00179	CcSEcCtD
Mitoxantrone—Renal failure—Methotrexate—ankylosing spondylitis	0.000315	0.00177	CcSEcCtD
Mitoxantrone—Stomatitis—Methotrexate—ankylosing spondylitis	0.000312	0.00176	CcSEcCtD
Mitoxantrone—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000311	0.00175	CcSEcCtD
Mitoxantrone—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000311	0.00175	CcSEcCtD
Mitoxantrone—Malaise—Dexamethasone—ankylosing spondylitis	0.00031	0.00175	CcSEcCtD
Mitoxantrone—Malaise—Betamethasone—ankylosing spondylitis	0.00031	0.00175	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000309	0.00174	CcSEcCtD
Mitoxantrone—Oedema—Triamcinolone—ankylosing spondylitis	0.000309	0.00174	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000309	0.00174	CcSEcCtD
Mitoxantrone—Arrhythmia—Prednisone—ankylosing spondylitis	0.000307	0.00173	CcSEcCtD
Mitoxantrone—Infection—Triamcinolone—ankylosing spondylitis	0.000307	0.00173	CcSEcCtD
Mitoxantrone—Sweating—Methotrexate—ankylosing spondylitis	0.000307	0.00173	CcSEcCtD
Mitoxantrone—Infection—Methylprednisolone—ankylosing spondylitis	0.000307	0.00173	CcSEcCtD
Mitoxantrone—Haematuria—Methotrexate—ankylosing spondylitis	0.000305	0.00172	CcSEcCtD
Mitoxantrone—Shock—Triamcinolone—ankylosing spondylitis	0.000304	0.00171	CcSEcCtD
Mitoxantrone—Alopecia—Prednisone—ankylosing spondylitis	0.000304	0.00171	CcSEcCtD
Mitoxantrone—Shock—Methylprednisolone—ankylosing spondylitis	0.000304	0.00171	CcSEcCtD
Mitoxantrone—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000302	0.0017	CcSEcCtD
Mitoxantrone—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000302	0.0017	CcSEcCtD
Mitoxantrone—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000301	0.0017	CcSEcCtD
Mitoxantrone—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.0003	0.00169	CcSEcCtD
Mitoxantrone—Erythema—Prednisone—ankylosing spondylitis	0.000299	0.00169	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000299	0.00168	CcSEcCtD
Mitoxantrone—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000299	0.00168	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000298	0.00168	CcSEcCtD
Mitoxantrone—Convulsion—Dexamethasone—ankylosing spondylitis	0.000298	0.00168	CcSEcCtD
Mitoxantrone—Convulsion—Betamethasone—ankylosing spondylitis	0.000298	0.00168	CcSEcCtD
Mitoxantrone—Hypertension—Betamethasone—ankylosing spondylitis	0.000297	0.00167	CcSEcCtD
Mitoxantrone—Hypertension—Dexamethasone—ankylosing spondylitis	0.000297	0.00167	CcSEcCtD
Mitoxantrone—Myalgia—Betamethasone—ankylosing spondylitis	0.000293	0.00165	CcSEcCtD
Mitoxantrone—Myalgia—Dexamethasone—ankylosing spondylitis	0.000293	0.00165	CcSEcCtD
Mitoxantrone—Anxiety—Dexamethasone—ankylosing spondylitis	0.000292	0.00164	CcSEcCtD
Mitoxantrone—Anxiety—Betamethasone—ankylosing spondylitis	0.000292	0.00164	CcSEcCtD
Mitoxantrone—Discomfort—Betamethasone—ankylosing spondylitis	0.000289	0.00163	CcSEcCtD
Mitoxantrone—Discomfort—Dexamethasone—ankylosing spondylitis	0.000289	0.00163	CcSEcCtD
Mitoxantrone—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000289	0.00163	CcSEcCtD
Mitoxantrone—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000288	0.00162	CcSEcCtD
Mitoxantrone—Pain—Prednisolone—ankylosing spondylitis	0.000288	0.00162	CcSEcCtD
Mitoxantrone—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000288	0.00162	CcSEcCtD
Mitoxantrone—Hepatitis—Methotrexate—ankylosing spondylitis	0.000288	0.00162	CcSEcCtD
Mitoxantrone—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000285	0.00161	CcSEcCtD
Mitoxantrone—Vision blurred—Prednisone—ankylosing spondylitis	0.000282	0.00159	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000282	0.00159	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000281	0.00158	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000281	0.00158	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000281	0.00158	CcSEcCtD
Mitoxantrone—Oedema—Betamethasone—ankylosing spondylitis	0.000281	0.00158	CcSEcCtD
Mitoxantrone—Oedema—Dexamethasone—ankylosing spondylitis	0.000281	0.00158	CcSEcCtD
Mitoxantrone—Infection—Dexamethasone—ankylosing spondylitis	0.000279	0.00157	CcSEcCtD
Mitoxantrone—Infection—Betamethasone—ankylosing spondylitis	0.000279	0.00157	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000278	0.00157	CcSEcCtD
Mitoxantrone—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000278	0.00156	CcSEcCtD
Mitoxantrone—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000277	0.00156	CcSEcCtD
Mitoxantrone—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000277	0.00156	CcSEcCtD
Mitoxantrone—Anaemia—Prednisone—ankylosing spondylitis	0.000277	0.00156	CcSEcCtD
Mitoxantrone—Shock—Betamethasone—ankylosing spondylitis	0.000276	0.00156	CcSEcCtD
Mitoxantrone—Shock—Dexamethasone—ankylosing spondylitis	0.000276	0.00156	CcSEcCtD
Mitoxantrone—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000276	0.00155	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000275	0.00155	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000275	0.00155	CcSEcCtD
Mitoxantrone—Tachycardia—Betamethasone—ankylosing spondylitis	0.000274	0.00154	CcSEcCtD
Mitoxantrone—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000274	0.00154	CcSEcCtD
Mitoxantrone—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000272	0.00153	CcSEcCtD
Mitoxantrone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000272	0.00153	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000271	0.00153	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000271	0.00153	CcSEcCtD
Mitoxantrone—Malaise—Prednisone—ankylosing spondylitis	0.00027	0.00152	CcSEcCtD
Mitoxantrone—Anorexia—Betamethasone—ankylosing spondylitis	0.000268	0.00151	CcSEcCtD
Mitoxantrone—Anorexia—Dexamethasone—ankylosing spondylitis	0.000268	0.00151	CcSEcCtD
Mitoxantrone—Urticaria—Prednisolone—ankylosing spondylitis	0.000267	0.00151	CcSEcCtD
Mitoxantrone—Fatigue—Triamcinolone—ankylosing spondylitis	0.000267	0.0015	CcSEcCtD
Mitoxantrone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000266	0.0015	CcSEcCtD
Mitoxantrone—Pain—Triamcinolone—ankylosing spondylitis	0.000265	0.00149	CcSEcCtD
Mitoxantrone—Hypotension—Betamethasone—ankylosing spondylitis	0.000262	0.00148	CcSEcCtD
Mitoxantrone—Hypotension—Dexamethasone—ankylosing spondylitis	0.000262	0.00148	CcSEcCtD
Mitoxantrone—Convulsion—Prednisone—ankylosing spondylitis	0.000259	0.00146	CcSEcCtD
Mitoxantrone—Hypertension—Prednisone—ankylosing spondylitis	0.000259	0.00146	CcSEcCtD
Mitoxantrone—Chills—Methotrexate—ankylosing spondylitis	0.000258	0.00145	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000256	0.00144	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000256	0.00144	CcSEcCtD
Mitoxantrone—Arthralgia—Prednisone—ankylosing spondylitis	0.000255	0.00144	CcSEcCtD
Mitoxantrone—Myalgia—Prednisone—ankylosing spondylitis	0.000255	0.00144	CcSEcCtD
Mitoxantrone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000255	0.00144	CcSEcCtD
Mitoxantrone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000254	0.00143	CcSEcCtD
Mitoxantrone—Anxiety—Prednisone—ankylosing spondylitis	0.000254	0.00143	CcSEcCtD
Mitoxantrone—Alopecia—Methotrexate—ankylosing spondylitis	0.000254	0.00143	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000252	0.00142	CcSEcCtD
Mitoxantrone—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000252	0.00142	CcSEcCtD
Mitoxantrone—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000252	0.00142	CcSEcCtD
Mitoxantrone—Discomfort—Prednisone—ankylosing spondylitis	0.000252	0.00142	CcSEcCtD
Mitoxantrone—Erythema—Methotrexate—ankylosing spondylitis	0.00025	0.00141	CcSEcCtD
Mitoxantrone—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000248	0.0014	CcSEcCtD
Mitoxantrone—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000247	0.00139	CcSEcCtD
Mitoxantrone—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000247	0.00139	CcSEcCtD
Mitoxantrone—Urticaria—Triamcinolone—ankylosing spondylitis	0.000246	0.00138	CcSEcCtD
Mitoxantrone—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000245	0.00138	CcSEcCtD
Mitoxantrone—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000245	0.00138	CcSEcCtD
Mitoxantrone—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000245	0.00138	CcSEcCtD
Mitoxantrone—Oedema—Prednisone—ankylosing spondylitis	0.000244	0.00138	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000244	0.00138	CcSEcCtD
Mitoxantrone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000244	0.00137	CcSEcCtD
Mitoxantrone—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000244	0.00137	CcSEcCtD
Mitoxantrone—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000244	0.00137	CcSEcCtD
Mitoxantrone—Infection—Prednisone—ankylosing spondylitis	0.000243	0.00137	CcSEcCtD
Mitoxantrone—Back pain—Methotrexate—ankylosing spondylitis	0.000242	0.00136	CcSEcCtD
Mitoxantrone—Fatigue—Dexamethasone—ankylosing spondylitis	0.000242	0.00136	CcSEcCtD
Mitoxantrone—Fatigue—Betamethasone—ankylosing spondylitis	0.000242	0.00136	CcSEcCtD
Mitoxantrone—Shock—Prednisone—ankylosing spondylitis	0.00024	0.00135	CcSEcCtD
Mitoxantrone—Pain—Dexamethasone—ankylosing spondylitis	0.00024	0.00135	CcSEcCtD
Mitoxantrone—Pain—Betamethasone—ankylosing spondylitis	0.00024	0.00135	CcSEcCtD
Mitoxantrone—Tachycardia—Prednisone—ankylosing spondylitis	0.000239	0.00134	CcSEcCtD
Mitoxantrone—Skin disorder—Prednisone—ankylosing spondylitis	0.000237	0.00134	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000236	0.00133	CcSEcCtD
Mitoxantrone—Vision blurred—Methotrexate—ankylosing spondylitis	0.000236	0.00133	CcSEcCtD
Mitoxantrone—Anorexia—Prednisone—ankylosing spondylitis	0.000233	0.00131	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000232	0.00131	CcSEcCtD
Mitoxantrone—Anaemia—Methotrexate—ankylosing spondylitis	0.000231	0.0013	CcSEcCtD
Mitoxantrone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000231	0.0013	CcSEcCtD
Mitoxantrone—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000231	0.0013	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000229	0.00129	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000229	0.00129	CcSEcCtD
Mitoxantrone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000228	0.00128	CcSEcCtD
Mitoxantrone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000227	0.00128	CcSEcCtD
Mitoxantrone—Malaise—Methotrexate—ankylosing spondylitis	0.000226	0.00127	CcSEcCtD
Mitoxantrone—Leukopenia—Methotrexate—ankylosing spondylitis	0.000224	0.00126	CcSEcCtD
Mitoxantrone—Urticaria—Dexamethasone—ankylosing spondylitis	0.000223	0.00126	CcSEcCtD
Mitoxantrone—Urticaria—Betamethasone—ankylosing spondylitis	0.000223	0.00126	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000223	0.00125	CcSEcCtD
Mitoxantrone—Asthenia—Triamcinolone—ankylosing spondylitis	0.000222	0.00125	CcSEcCtD
Mitoxantrone—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000222	0.00125	CcSEcCtD
Mitoxantrone—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000222	0.00125	CcSEcCtD
Mitoxantrone—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000222	0.00125	CcSEcCtD
Mitoxantrone—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000222	0.00125	CcSEcCtD
Mitoxantrone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000221	0.00125	CcSEcCtD
Mitoxantrone—Paraesthesia—Prednisone—ankylosing spondylitis	0.000219	0.00124	CcSEcCtD
Mitoxantrone—Cough—Methotrexate—ankylosing spondylitis	0.000218	0.00123	CcSEcCtD
Mitoxantrone—Convulsion—Methotrexate—ankylosing spondylitis	0.000217	0.00122	CcSEcCtD
Mitoxantrone—Dyspepsia—Prednisone—ankylosing spondylitis	0.000215	0.00121	CcSEcCtD
Mitoxantrone—Arthralgia—Methotrexate—ankylosing spondylitis	0.000213	0.0012	CcSEcCtD
Mitoxantrone—Chest pain—Methotrexate—ankylosing spondylitis	0.000213	0.0012	CcSEcCtD
Mitoxantrone—Myalgia—Methotrexate—ankylosing spondylitis	0.000213	0.0012	CcSEcCtD
Mitoxantrone—Decreased appetite—Prednisone—ankylosing spondylitis	0.000212	0.0012	CcSEcCtD
Mitoxantrone—Rash—Prednisolone—ankylosing spondylitis	0.000212	0.00119	CcSEcCtD
Mitoxantrone—Dermatitis—Prednisolone—ankylosing spondylitis	0.000212	0.00119	CcSEcCtD
Mitoxantrone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000211	0.00119	CcSEcCtD
Mitoxantrone—Fatigue—Prednisone—ankylosing spondylitis	0.000211	0.00119	CcSEcCtD
Mitoxantrone—Headache—Prednisolone—ankylosing spondylitis	0.000211	0.00119	CcSEcCtD
Mitoxantrone—Discomfort—Methotrexate—ankylosing spondylitis	0.000211	0.00119	CcSEcCtD
Mitoxantrone—Constipation—Prednisone—ankylosing spondylitis	0.000209	0.00118	CcSEcCtD
Mitoxantrone—Confusional state—Methotrexate—ankylosing spondylitis	0.000206	0.00116	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000204	0.00115	CcSEcCtD
Mitoxantrone—Infection—Methotrexate—ankylosing spondylitis	0.000203	0.00114	CcSEcCtD
Mitoxantrone—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000201	0.00113	CcSEcCtD
Mitoxantrone—Asthenia—Dexamethasone—ankylosing spondylitis	0.000201	0.00113	CcSEcCtD
Mitoxantrone—Asthenia—Betamethasone—ankylosing spondylitis	0.000201	0.00113	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.0002	0.00113	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.0002	0.00113	CcSEcCtD
Mitoxantrone—Nausea—Prednisolone—ankylosing spondylitis	0.0002	0.00113	CcSEcCtD
Mitoxantrone—Skin disorder—Methotrexate—ankylosing spondylitis	0.000198	0.00112	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000197	0.00111	CcSEcCtD
Mitoxantrone—Vomiting—Triamcinolone—ankylosing spondylitis	0.000197	0.00111	CcSEcCtD
Mitoxantrone—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000196	0.00111	CcSEcCtD
Mitoxantrone—Rash—Triamcinolone—ankylosing spondylitis	0.000195	0.0011	CcSEcCtD
Mitoxantrone—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000195	0.0011	CcSEcCtD
Mitoxantrone—Anorexia—Methotrexate—ankylosing spondylitis	0.000195	0.0011	CcSEcCtD
Mitoxantrone—Rash—Methylprednisolone—ankylosing spondylitis	0.000195	0.0011	CcSEcCtD
Mitoxantrone—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000194	0.0011	CcSEcCtD
Mitoxantrone—Urticaria—Prednisone—ankylosing spondylitis	0.000194	0.00109	CcSEcCtD
Mitoxantrone—Headache—Triamcinolone—ankylosing spondylitis	0.000194	0.00109	CcSEcCtD
Mitoxantrone—Headache—Methylprednisolone—ankylosing spondylitis	0.000193	0.00109	CcSEcCtD
Mitoxantrone—Body temperature increased—Prednisone—ankylosing spondylitis	0.000193	0.00109	CcSEcCtD
Mitoxantrone—Abdominal pain—Prednisone—ankylosing spondylitis	0.000193	0.00109	CcSEcCtD
Mitoxantrone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000192	0.00108	CcSEcCtD
Mitoxantrone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000192	0.00108	CcSEcCtD
Mitoxantrone—Hypotension—Methotrexate—ankylosing spondylitis	0.000191	0.00108	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000186	0.00105	CcSEcCtD
Mitoxantrone—Nausea—Triamcinolone—ankylosing spondylitis	0.000184	0.00104	CcSEcCtD
Mitoxantrone—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000183	0.00103	CcSEcCtD
Mitoxantrone—Nausea—Methylprednisolone—ankylosing spondylitis	0.000183	0.00103	CcSEcCtD
Mitoxantrone—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000182	0.00103	CcSEcCtD
Mitoxantrone—Somnolence—Methotrexate—ankylosing spondylitis	0.000182	0.00102	CcSEcCtD
Mitoxantrone—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00018	0.00101	CcSEcCtD
Mitoxantrone—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00018	0.00101	CcSEcCtD
Mitoxantrone—Vomiting—Dexamethasone—ankylosing spondylitis	0.000178	0.00101	CcSEcCtD
Mitoxantrone—Vomiting—Betamethasone—ankylosing spondylitis	0.000178	0.00101	CcSEcCtD
Mitoxantrone—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000178	0.001	CcSEcCtD
Mitoxantrone—Rash—Dexamethasone—ankylosing spondylitis	0.000177	0.000997	CcSEcCtD
Mitoxantrone—Rash—Betamethasone—ankylosing spondylitis	0.000177	0.000997	CcSEcCtD
Mitoxantrone—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000177	0.000996	CcSEcCtD
Mitoxantrone—Dermatitis—Betamethasone—ankylosing spondylitis	0.000177	0.000996	CcSEcCtD
Mitoxantrone—Fatigue—Methotrexate—ankylosing spondylitis	0.000176	0.000992	CcSEcCtD
Mitoxantrone—Headache—Betamethasone—ankylosing spondylitis	0.000176	0.000991	CcSEcCtD
Mitoxantrone—Headache—Dexamethasone—ankylosing spondylitis	0.000176	0.000991	CcSEcCtD
Mitoxantrone—Asthenia—Prednisone—ankylosing spondylitis	0.000175	0.000988	CcSEcCtD
Mitoxantrone—Pain—Methotrexate—ankylosing spondylitis	0.000175	0.000984	CcSEcCtD
Mitoxantrone—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000168	0.000948	CcSEcCtD
Mitoxantrone—Diarrhoea—Prednisone—ankylosing spondylitis	0.000167	0.000942	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000167	0.000941	CcSEcCtD
Mitoxantrone—Nausea—Dexamethasone—ankylosing spondylitis	0.000167	0.000939	CcSEcCtD
Mitoxantrone—Nausea—Betamethasone—ankylosing spondylitis	0.000167	0.000939	CcSEcCtD
Mitoxantrone—Urticaria—Methotrexate—ankylosing spondylitis	0.000162	0.000914	CcSEcCtD
Mitoxantrone—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000161	0.00091	CcSEcCtD
Mitoxantrone—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000161	0.00091	CcSEcCtD
Mitoxantrone—Vomiting—Prednisone—ankylosing spondylitis	0.000155	0.000876	CcSEcCtD
Mitoxantrone—Rash—Prednisone—ankylosing spondylitis	0.000154	0.000868	CcSEcCtD
Mitoxantrone—Dermatitis—Prednisone—ankylosing spondylitis	0.000154	0.000868	CcSEcCtD
Mitoxantrone—Headache—Prednisone—ankylosing spondylitis	0.000153	0.000863	CcSEcCtD
Mitoxantrone—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00015	0.000848	CcSEcCtD
Mitoxantrone—Asthenia—Methotrexate—ankylosing spondylitis	0.000147	0.000826	CcSEcCtD
Mitoxantrone—Nausea—Prednisone—ankylosing spondylitis	0.000145	0.000818	CcSEcCtD
Mitoxantrone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00014	0.000787	CcSEcCtD
Mitoxantrone—Vomiting—Methotrexate—ankylosing spondylitis	0.00013	0.000732	CcSEcCtD
Mitoxantrone—Rash—Methotrexate—ankylosing spondylitis	0.000129	0.000726	CcSEcCtD
Mitoxantrone—Dermatitis—Methotrexate—ankylosing spondylitis	0.000129	0.000725	CcSEcCtD
Mitoxantrone—Headache—Methotrexate—ankylosing spondylitis	0.000128	0.000721	CcSEcCtD
Mitoxantrone—Nausea—Methotrexate—ankylosing spondylitis	0.000121	0.000684	CcSEcCtD
